Amid all the pomp, circumstance and sans serif fonts in Apple's ($APPL) latest product launch, the company took a break from pumping expensive new gadgetry to unveil a piece of software with the potential to change the medical research landscape. Dubbed ResearchKit, Apple's new platform promises to transform the world's hundreds of millions of iPhones into handheld gatherers of clinical data, which some say will usher in a new era of biomedical science but could well amount to more questions than answers. Report